Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,442

The DOI matches its Crossref record.

DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION

HORNYKIEWICZ, OLEH·1966·Pharmacological Reviews

Abstract

The whole body of evidence discussed in this article shows that brain dopamine can be regarded as a strong candidate for a physiologically active substance, regulating the functioning of some extrapyramidal centers, especially substantia nigra, striatum and pallidum. The following findings provide strong support for this view: The dopamine is mainly confined to the extrapyramidal regions mentioned; in these regions, the amine is localized in specific neurons and nerve terminals; its rate of turnover is of a high order of magnitude; is there a correlation between itsconcentration in the brain and the functional state of the extrapyramidal centers following administration of certain drugs; there is a striking relationship between some extrapyramidal disorders (drug-induced and genuine parkinsonism) and the lack of the amine in the substantia nigra, the striatum and the pallidum; and, finally, that substantia nigra exerts a direct influence on the concentration of the amine in the striatum by virtue of the nigro-striatal dopamine-containing fibers. In the extrapyramidal centers, dopamine may have either inhibitory or excitatory activity. Neurophysiological evidence obtained in different species points to a predominantly inhibitory activity of dopamine on single neurons of the brain. Evidence showing that in the retina and in the median eminence (including the pituitary stalk) dopamine may be the predominant catecholamine argues in favor of a specific function of the amine in these brain structures, although there are at present no direct findings to prove this suggestion. From the evidence discussed in this article a good case can be made for the concept that the physiological activity of the brain dopamine is quite different from that of brain norepinephrine. There are as yet., however, no experiments to positively show that dopamine is a true neuro-transmitter substance in the brain. All central dopamine effects could equally well be explained by assuming that the amine is a modifier of synaptic transmission. Therefore, in order to establish dopamine unequivocally as a central neurotransmitter substance, there is still one crucial experiment to be done: to demonstrate that upon stimulation of the relevant parts of the brain, dopamine is in fact released at synapses to exert by itself an effect on the neurons standing in synaptic relationship with the stimulated dopamine-containing terminals. It is to be hoped that we shall not have to wait too long for this experiment to be performed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0031-6997(25)07154-6

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 1,442

Metadata

Authors
HORNYKIEWICZ, O.
Venue
Pharmacological Reviews
Publisher
Elsevier BV
Published
1966-06
Volume
18
Issue
2
Pages
925-964
ISSN
0031-6997 (ISSN-L)
OpenAlex
W2164398262
Cited by
1,442
References
0
FWCI
15.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION. https://app.cochat.ai/papers/10.1016/s0031-6997(25)07154-6
The paper
HORNYKIEWICZ, O. (1966). DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION. Pharmacological Reviews. https://doi.org/10.1016/s0031-6997(25)07154-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.